SCHEMBL7780145

SCHEMBL7780145

CC=Cn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(Cl)cc2Cl)c1C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 15/20 0.51
PTGS2 P35354 15/20 0.51
PDPK1 O15530 5/20 0.43
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA4 P22748 2/20 0.37
CA7 P43166 2/20 0.37
PTGES O14684 1/20 0.37
HDAC3 O15379 1/20 0.37
CA12 O43570 1/20 0.37
PDE5A O76074 1/20 0.37
ABCB11 O95342 1/20 0.37
MT-CO2 P00403 1/20 0.37
LMNA P02545 1/20 0.37
CA3 P07451 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX5 P09917 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779756 0.91 PTGS2 (0.43) PTGS1PTGS2CYP2C9
SCHEMBL7773180 0.88 PTGS2 (0.53) PTGS1PTGS2PDPK1CA1CA2
SCHEMBL7777716 0.85 PTGS2 (0.55) PTGS1PTGS2PDPK1CA1CA2
SCHEMBL8634407 0.84 PTGS2 (0.39) PTGS1PTGS2CA2CA12CYP3A4
SCHEMBL7777892 0.82 PTGS2 (0.66) PTGS1PTGS2PDPK1CA1CA2
SCHEMBL7779595 0.81 PTGS2 (0.49) PTGS1PTGS2PDPK1CA1CA2
SCHEMBL7778057 0.81 PTGS1 (0.51) PTGS1PTGS2PDPK1CA1CA2
SCHEMBL7773256 0.81 PTGS2 (0.54) PTGS1PTGS2PDPK1CA1CA2
SCHEMBL7780060 0.81 PTGS2 (0.66) PTGS1PTGS2CA1CA2CA4
SCHEMBL7780102 0.81 PTGS2 (0.54) PTGS1PTGS2PDPK1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed